Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan vs Amlodipine in Hypertensive T2DM Patients
NCT05173025Phase 4Unknown
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jan 2018
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fimasartan in hypertension (HTN) (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Serum Angiotensin(1-7) Level at 12 weeks. Status: unknown.
02
Drugs
fimasartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05173025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05173025.